Log in

Cantel Medical Stock Forecast, Price & News

-0.53 (-1.10 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $47.84
50-Day Range
MA: $46.62
52-Week Range
Now: $47.84
Volume244,287 shs
Average Volume588,259 shs
Market Capitalization$2.02 billion
P/E RatioN/A
Dividend YieldN/A
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Read More
Cantel Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryHealth Care Equipment
Current SymbolNYSEARCA:CMD



Sales & Book Value

Annual SalesN/A



Market Cap$2.02 billion
Next Earnings Date12/8/2020 (Estimated)
-0.53 (-1.10 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cantel Medical (NYSEARCA:CMD) Frequently Asked Questions

How has Cantel Medical's stock price been impacted by Coronavirus?

Cantel Medical's stock was trading at $49.70 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CMD stock has decreased by 3.7% and is now trading at $47.84.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Cantel Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 1 sell rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cantel Medical

When is Cantel Medical's next earnings date?

Cantel Medical is scheduled to release its next quarterly earnings announcement on Tuesday, December 8th 2020.
View our earnings forecast for Cantel Medical

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSEARCA:CMD) issued its quarterly earnings results on Thursday, September, 17th. The medical instruments supplier reported $0.24 EPS for the quarter, beating the consensus estimate of $0.08 by $0.16. The medical instruments supplier had revenue of $233.40 million for the quarter, compared to analyst estimates of $232.55 million. The business's quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.63 EPS.
View Cantel Medical's earnings history

How often does Cantel Medical pay dividends? What is the dividend yield for Cantel Medical?

Cantel Medical declared a dividend on Wednesday, December 18th. Shareholders of record on Friday, January 17th will be paid a dividend of $0.105 per share on Friday, January 31st. The ex-dividend date of this dividend is Thursday, January 16th. This is a positive change from Cantel Medical's previous dividend of $0.10.
View Cantel Medical's dividend history

What guidance has Cantel Medical issued on next quarter's earnings?

Cantel Medical updated its first quarter 2021 Pre-Market earnings guidance on Thursday, October, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $290-295 million, compared to the consensus revenue estimate of $256.2 million.

What price target have analysts set for CMD?

4 Wall Street analysts have issued 12 month price objectives for Cantel Medical's stock. Their forecasts range from $51.00 to $70.00. On average, they expect Cantel Medical's share price to reach $62.75 in the next year. This suggests a possible upside of 31.2% from the stock's current price.
View analysts' price targets for Cantel Medical

Who are some of Cantel Medical's key competitors?

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include Therapix Biosciences (TRPX), Eastman Chemical (EMN), Gilead Sciences (GILD), Pfizer (PFE), Steris (STE), AT&T (T), WestRock (WRK), AbbVie (ABBV), Carnival Co. & (CCL) and General Mills (GIS).

Who are Cantel Medical's key executives?

Cantel Medical's management team includes the following people:
  • Mr. Charles Michael Diker, Chairman & Member of Office of the Chairman (Age 85, Pay $520.45k)
  • Mr. George L. Fotiades, CEO, Vice Chairman & Member of Office of the Chairman (Age 66, Pay $254.42k)
  • Mr. Peter G. Clifford, Pres & COO (Age 50, Pay $852k)
  • Mr. Shaun M. Blakeman, Sr. VP, CFO & Member of Office of the Chairman (Age 42, Pay $205.04k)
  • Mr. Seth M. Yellin, Exec. VP & Chief Growth Officer (Age 46, Pay $635.33k)
  • Mr. Brian R. Capone, Sr. VP, Corp. Controller & Chief Accounting Officer (Age 45)
  • Mr. Michael Drexel, CTO & Sr. VP
  • Mr. Matthew Micowski, VP of Corp. FP&A and Investor Relations
  • Mr. Jeffrey Z. Mann, Sr. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 48)
  • Ms. Milicent Brooks, Head of Corp. Communications

What is Cantel Medical's stock symbol?

Cantel Medical trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CMD."

Who are Cantel Medical's major shareholders?

Cantel Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Comerica Bank (0.17%), State of New Jersey Common Pension Fund D (0.10%), Kornitzer Capital Management Inc. KS (0.05%), Dupont Capital Management Corp (0.04%), Emerald Advisers LLC (0.02%) and New Mexico Educational Retirement Board (0.02%). Company insiders that own Cantel Medical stock include Anthony B Evnin, Brian Capone, Charles M Diker, George L Fotiades, Jeffrey Z Mann, Lawrence Conway, Mark N Diker and Ronnie Myers.
View institutional ownership trends for Cantel Medical

Which institutional investors are selling Cantel Medical stock?

CMD stock was sold by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, Kornitzer Capital Management Inc. KS, State of New Jersey Common Pension Fund D, New Mexico Educational Retirement Board, and New Mexico Educational Retirement Board.
View insider buying and selling activity for Cantel Medical

Which institutional investors are buying Cantel Medical stock?

CMD stock was purchased by a variety of institutional investors in the last quarter, including Comerica Bank, Dupont Capital Management Corp, Emerald Advisers LLC, and Emerald Mutual Fund Advisers Trust. Company insiders that have bought Cantel Medical stock in the last two years include Anthony B Evnin, George L Fotiades, Jeffrey Z Mann, and Mark N Diker.
View insider buying and selling activity for Cantel Medical

How do I buy shares of Cantel Medical?

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cantel Medical's stock price today?

One share of CMD stock can currently be purchased for approximately $47.84.

How big of a company is Cantel Medical?

Cantel Medical has a market capitalization of $2.02 billion. Cantel Medical employs 3,669 workers across the globe.

What is Cantel Medical's official website?

The official website for Cantel Medical is www.proshares.com.

How can I contact Cantel Medical?

Cantel Medical's mailing address is 7501 Wisconsin Avenue Suite 1000 - East Tower, Bethesda, MD 20814, United States. The medical instruments supplier can be reached via phone at +1-240-4976400.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.